Could there be a fix for BMY’s nuke problem? In the INHX deal, BMY acquired not only INX-189, but also a single-isomer version of INX-189, called INX-005 (#msg-69407640). If the toxicity in BMS-986094 comes from the isomer not present in INX-005, then maybe BMY has a workaround. Not likely, but possible.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”